Johan Boender

493 total citations
18 papers, 303 citations indexed

About

Johan Boender is a scholar working on Hematology, Surgery and Genetics. According to data from OpenAlex, Johan Boender has authored 18 papers receiving a total of 303 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Hematology, 6 papers in Surgery and 3 papers in Genetics. Recurrent topics in Johan Boender's work include Platelet Disorders and Treatments (14 papers), Blood groups and transfusion (8 papers) and Heparin-Induced Thrombocytopenia and Thrombosis (6 papers). Johan Boender is often cited by papers focused on Platelet Disorders and Treatments (14 papers), Blood groups and transfusion (8 papers) and Heparin-Induced Thrombocytopenia and Thrombosis (6 papers). Johan Boender collaborates with scholars based in Netherlands, Austria and United Kingdom. Johan Boender's co-authors include Frank W.G. Leebeek, Marieke J.H.A. Kruip, Marjon H. Cnossen, Jeroen Eikenboom, Karin Fijnvandraat, Joke de Meris, Johanna G. van der Bom, Karina Meijer, Moniek P.M. de Maat and Evelien P. Mauser‐Bunschoten and has published in prestigious journals such as Blood, Neurology and Scientific Reports.

In The Last Decade

Johan Boender

17 papers receiving 291 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Johan Boender Netherlands 11 227 62 56 52 35 18 303
Ana Catalina Kempfer Argentina 9 232 1.0× 36 0.6× 28 0.5× 100 1.9× 19 0.5× 28 295
Nejat Akar Türkiye 11 145 0.6× 52 0.8× 42 0.8× 125 2.4× 18 0.5× 31 300
J. Walton United Kingdom 7 268 1.2× 37 0.6× 31 0.6× 12 0.2× 123 3.5× 9 336
M. Kloss Germany 8 166 0.7× 25 0.4× 18 0.3× 44 0.8× 20 0.6× 11 337
M. Picó Spain 11 167 0.7× 55 0.9× 50 0.9× 7 0.1× 41 1.2× 20 294
Corrado Mammì Italy 8 80 0.4× 135 2.2× 24 0.4× 20 0.4× 201 5.7× 28 389
Philippe Beurrier France 7 59 0.3× 23 0.4× 12 0.2× 34 0.7× 35 1.0× 17 170
Edouard Haller Switzerland 6 80 0.4× 26 0.4× 35 0.6× 25 0.5× 12 0.3× 16 302
Rosario Salazar‐Riojas Mexico 10 137 0.6× 37 0.6× 6 0.1× 85 1.6× 6 0.2× 38 336
Kaoru Takase‐Minegishi Japan 8 45 0.2× 29 0.5× 19 0.3× 90 1.7× 6 0.2× 16 319

Countries citing papers authored by Johan Boender

Since Specialization
Citations

This map shows the geographic impact of Johan Boender's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Johan Boender with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Johan Boender more than expected).

Fields of papers citing papers by Johan Boender

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Johan Boender. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Johan Boender. The network helps show where Johan Boender may publish in the future.

Co-authorship network of co-authors of Johan Boender

This figure shows the co-authorship network connecting the top 25 collaborators of Johan Boender. A scholar is included among the top collaborators of Johan Boender based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Johan Boender. Johan Boender is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Atiq, Ferdows, Johan Boender, Waander L. van Heerde, et al.. (2022). Desmopressin response depends on the presence and type of genetic variants in patients with type 1 and type 2 von Willebrand disease. Blood Advances. 6(18). 5317–5326. 9 indexed citations
2.
Atiq, Ferdows, Johan Boender, Waander L. van Heerde, et al.. (2022). Importance of Genotyping in von Willebrand Disease to Elucidate Pathogenic Mechanisms and Variability in Phenotype. HemaSphere. 6(6). e718–e718. 17 indexed citations
3.
Boender, Johan, Ferdows Atiq, Marjon H. Cnossen, et al.. (2021). Von Willebrand Factor Multimer Densitometric Analysis: Validation of the Clinical Accuracy and Clinical Implications in Von Willebrand Disease. HemaSphere. 5(3). e542–e542. 10 indexed citations
4.
Jong, Annika de, Richard Dirven, Johan Boender, et al.. (2020). Ex vivo Improvement of a von Willebrand Disease Type 2A Phenotype Using an Allele-Specific Small-Interfering RNA. Thrombosis and Haemostasis. 120(11). 1569–1579. 22 indexed citations
5.
Atiq, Ferdows, Johan Boender, Marjon H. Cnossen, et al.. (2019). von Willebrand factor and factor VIII levels after desmopressin are associated with bleeding phenotype in type 1 VWD. Blood Advances. 3(24). 4147–4154. 12 indexed citations
6.
Boender, Johan, Ron A. A. Mathôt, Karina Meijer, et al.. (2018). Analysis of current perioperative management with Haemate® P/Humate P® in von Willebrand disease: Identifying the need for personalized treatment. Haemophilia. 24(3). 460–470. 28 indexed citations
7.
Boender, Johan, Jeroen Eikenboom, Johanna G. van der Bom, et al.. (2018). Clinically relevant differences between assays for von Willebrand factor activity. Journal of Thrombosis and Haemostasis. 16(12). 2413–2424. 37 indexed citations
8.
Wolters, Frank J., Johan Boender, Paul S. de Vries, et al.. (2018). Von Willebrand factor and ADAMTS13 activity in relation to risk of dementia: a population-based study. Scientific Reports. 8(1). 5474–5474. 20 indexed citations
9.
Boender, Johan, et al.. (2017). Tightrope walking with Glanzmann’s disease. 4(1). 29–31. 1 indexed citations
10.
Boender, Johan, Jeroen Eikenboom, Eveline P. Mauser‐Bunschoten, et al.. (2017). Plasma levels of plasminogen activator inhibitor‐1 and bleeding phenotype in patients with von Willebrand disease. Haemophilia. 23(3). 437–443. 4 indexed citations
11.
Boender, Johan, Jeroen Eikenboom, Karin Fijnvandraat, et al.. (2016). No Association Between Normalization of VWF Levels and Bleeding Phenotype in Patients with Type 1 VWD - from the Win Study. Blood. 128(22). 2577–2577. 2 indexed citations
12.
Wolters, Frank J., Johan Boender, Albert Hofman, et al.. (2016). Von Willebrand Factor and the Risk of Dementia: A Population-Based Study (P1.092). Neurology. 86(16_supplement). 1 indexed citations
13.
Boender, Johan, Marieke J.H.A. Kruip, & Frank W.G. Leebeek. (2016). A diagnostic approach to mild bleeding disorders. Journal of Thrombosis and Haemostasis. 14(8). 1507–1516. 58 indexed citations
14.
Sedaghat, Sanaz, Paul S. de Vries, Johan Boender, et al.. (2016). von Willebrand Factor, ADAMTS13 Activity, and Decline in Kidney Function: A Population-Based Cohort Study. American Journal of Kidney Diseases. 68(5). 726–732. 11 indexed citations
15.
Meijden, Paola E. J. van der, Yukio Ozaki, Wolfram Ruf, et al.. (2015). Theme 1: Pathogenesis of venous thromboembolism (and post-thrombotic syndrome). Thrombosis Research. 136. S3–S7. 3 indexed citations
16.
Vries, Paul S. de, Johan Boender, Michelle Sonneveld, et al.. (2015). Genetic variants in the ADAMTS13 and SUPT3H genes are associated with ADAMTS13 activity. Blood. 125(25). 3949–3955. 18 indexed citations
17.
Sanders, Yvonne, Karin Fijnvandraat, Johan Boender, et al.. (2015). Bleeding spectrum in children with moderate or severe von Willebrand disease: Relevance of pediatric‐specific bleeding. American Journal of Hematology. 90(12). 1142–1148. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026